AI Article Synopsis
- - The National Lung Screening Trial showed that annual low-dose CT scans can reduce lung cancer deaths by 20%, indicating the potential effectiveness of LDCT screening programs.
- - A study conducted in 2013 surveyed 65 Lung Cancer Alliance Screening Centers to identify the challenges faced in implementing LDCT screening.
- - Key barriers included low patient demand and inadequate referrals from physicians; however, a majority of centers felt they did not require more staff or equipment, highlighting the need for better teamwork and addressing reimbursement issues to enhance screening uptake.
Article Abstract
Background: One of the largest, most expensive randomized, controlled trials, the National Lung Screening Trial, found that annual low-dose computed tomography (LDCT) scans led to a 20% reduction in lung cancer deaths.
Objectives: This study describes the characteristics and program implementation barriers experienced by LDCT screening programs in the United States.
Methods: Using a mixed-methods approach, Lung Cancer Alliance Screening Centers of Excellence were surveyed and interviewed in 2013. Representatives from 65 centers completed an electronic questionnaire, followed by in-depth interviews with 13 physicians and nurse navigators regarding their institution's screening programs.
Findings: Participants cited low patient demand and few physician referrals as barriers, but few centers reported needing additional staff or equipment. Those interviewed discussed the importance of a multidisciplinary team and overcoming barriers related to insurance reimbursement, costs, and physician knowledge to improve program implementation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1188/16.CJON.52-58 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!